Zutex-S 250mg/125mg Injection
Marketer
Zodak Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Zutex-S 250mg/125mg Injection
Combiflox-250 Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this medication requires adherence to the prescribed schedule; complete the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical attention. Inform your physician of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Uses of Zutex-S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Zutex-S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Zutex-S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Zutex-S 250mg/125mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is not advised.
How Zutex-S 250mg/125mg Injection works:
Zutex-S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, employs a dual-action mechanism. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. The beta-lactamase inhibitor, Sulbactam, counters bacterial resistance, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Zutex-S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Zutex-S, 250mg/125mg, is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to offspring; nevertheless, research involving human subjects remains scarce.
Breast feedingCAUTION
Administering Zutex-S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Zutex-S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zutex-S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Zutex-S 250mg/125mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification of Zutex-S 250mg/125mg Injection may be necessary. Physician consultation is advised. Altering the Zutex-S 250mg/125mg Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Zutex-S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Zutex-S 250mg/125mg Injection, seek medical advice from your physician.
Facts to Know About Zutex-S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently